Difference between revisions of "Allopurinol (Zyloprim)"
Jump to navigation
Jump to search
(Created page with "==General information== Class/mechanism: Xanthine oxidase inhibitor. <br>Route: PO/IV <br>Extravasation: unknown For conciseness and simplicity, HemOnc.org currently will foc...") |
m |
||
| Line 8: | Line 8: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
''No known antineoplastic properties. Used for tumor lysis syndrome treatment/prophylaxis.'' | ''No known antineoplastic properties. Used for tumor lysis syndrome treatment/prophylaxis.'' | ||
| + | |||
| + | ==History of changes in FDA indication== | ||
| + | * 8/19/1966: Initial FDA approval | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | |||
| + | [[Category:Drugs FDA approved in 1966]] | ||
Revision as of 16:43, 30 October 2014
General information
Class/mechanism: Xanthine oxidase inhibitor.
Route: PO/IV
Extravasation: unknown
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used for tumor lysis syndrome treatment/prophylaxis.
History of changes in FDA indication
- 8/19/1966: Initial FDA approval